Cargando…

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes

BACKGROUND: Interventions during primary HIV infection (PHI) can modify the clinical course during the chronic phase. The long-term effect of structured treatment interruptions (STI) followed by low doses of interleukin-2 (IL-2) in treated PHI patients is unknown. METHODS: Twelve PHI patients with v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sued, Omar, Ambrosioni, Juan, Nicolás, David, Manzardo, Christian, Agüero, Fernando, Claramonte, Xavier, Plana, Montserrat, Tuset, Montserrat, Pumarola, Tomás, Gallart, Teresa, Gatell, José María, Miró, José María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506046/ https://www.ncbi.nlm.nih.gov/pubmed/26186440 http://dx.doi.org/10.1371/journal.pone.0131651

Ejemplares similares

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)
por: Ambrosioni, Juan, et al.
Publicado: (2015)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection
por: Klein, Nigel, et al.
Publicado: (2013)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
por: Díaz, Natalia A., et al.
Publicado: (2021)

Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review
por: Diaz, Natalia A., et al.
Publicado: (2021)

Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children
por: Freguja, R, et al.
Publicado: (2020)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Overview of SARS-CoV-2 infection in adults living with HIV
por: Ambrosioni, Juan, et al.
Publicado: (2021)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy
por: Cristelli, Marina Pontello, et al.
Publicado: (2018)

Deciphering SARS-CoV-2 Virologic and Immunologic Features
por: Lebeau, Grégorie, et al.
Publicado: (2020)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
por: Joshi, Shivali S., et al.
Publicado: (2020)

Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine
por: Álvarez-Fernández, Carmen, et al.
Publicado: (2012)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
por: Vidal, Francesc, et al.
Publicado: (2012)

Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study
por: De La Mora, Lorena, et al.
Publicado: (2022)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

Use of a Terrestrial LIDAR Sensor for Drift Detection in Vineyard Spraying
por: Gil, Emilio, et al.
Publicado: (2013)

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions
por: Seoane, Elena, et al.
Publicado: (2008)

Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals
por: Guardo, Alberto Crespo, et al.
Publicado: (2013)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

Virology and Immunology Researchers Evolve with the Viruses We Study
por: Russell, Rodney S.
Publicado: (2020)

Insights into the virologic and immunologic features of SARS-COV-2
por: Polat, Ceylan, et al.
Publicado: (2021)

Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study
por: Cahn, Pedro, et al.
Publicado: (2014)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Cellular immune responses and changes in VL after a Dendritic Cells (DC)-based therapeutic vaccine in cART treated chronic HIV-infected patients with CD4 T cells above 450/mm
por: García, F, et al.
Publicado: (2012)

Virologic and Immunologic Evidence Supporting an Association between HHV-6 and Hashimoto's Thyroiditis
por: Caselli, Elisabetta, et al.
Publicado: (2012)

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
por: Leal, Lorna, et al.
Publicado: (2021)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
por: Gomes, Samara Tatielle M., et al.
Publicado: (2017)

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
por: Zamor, Philippe J., et al.
Publicado: (2021)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity
por: McGuinty, Michaeline, et al.
Publicado: (2020)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse
por: Vasiliver-Shamis, Gaia, et al.
Publicado: (2010)

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
por: Tukei, Vincent J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_78n4d358954crjne3rjfcaoej4